Literature DB >> 19934648

PKA and PKC partially rescue long QT type 1 phenotype by restoring channel-PIP2 interactions.

Alessandra Matavel1, Emiliano Medei, Coeli M B Lopes.   

Abstract

Long-QT syndrome causes torsade de pointes arrhythmia, ventricular fibrillation, and sudden death. The most commonly inherited form of long-QT syndrome, LQT1, is due to mutations on the potassium channel gene KCNQ1, which forms one of the main repolarizing cardiac K(+) channels, IKs. IKs has been shown to be regulated by both beta-adrenergic receptors, via protein kinase A (PKA), and by Gq protein coupled receptors (GqPCR), via protein kinase C (PKC) and phosphatidylinositol 4,5-bisphosphate (PIP(2)). These regulatory pathways were shown to crosstalk, with PKA phosphorylation increasing the apparent affinity of IKs to PIP(2). Here we study the effects of LQT1 mutations in putative PIP(2)-KCNQ1 interaction sites on regulation of IKs by PKA and GqPCR. The effect of the LQT1 mutations on IKs regulation was tested for mutations in conserved, positively charged amino acids, located in four distinct cytoplamic domains of the KCNQ1 subunit: R174C (S2-S3), R243C (S4-S5), R366Q (proximal c-terminus) and R555C (distal c-terminus). Mutations in the c-terminus of IKs (both proximal and distal) enhanced channel sensitivity to changes in membrane PIP(2) levels, consistent with a decrease in apparent channel-PIP(2) affinity. These mutant channels were more sensitive to inhibition caused by receptor mediated PIP(2)-depletion and more sensitive to stimulation of PIP(2) production, by overexpression of phosphatidylinositol-4-phosphate-5-kinase (PI5-kinase). In addition, c-terminus mutants showed a potentiated regulation by PKA. On the other hand, for the two cytoplasmic-loop mutations, an impaired activation by PKA was observed. The effects of the mutations on PKC stimulation of the channel paralleled the effects on PKA stimulation, suggesting that both regulatory inputs are similarly affected by the mutations. We tested whether PKC-mediated activation of IKs, similarly to the PKA-mediated activation, can regulate the channel response to PIP(2). After PKC activation, channel was less sensitive to changes in membrane PIP(2) levels, consistent with an increase in apparent channel-PIP(2) affinity. PKC-activated channel was less sensitive to inhibition caused by block of synthesis of PIP(2) by the lipid kinase inhibitor wortmannin and less sensitive to stimulation of PIP(2) production. Our data indicates that stimulation by PKA and PKC can partially rescue LQT1 mutant channels with weakened response to PIP(2) by strengthening channel interactions with PIP(2).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19934648     DOI: 10.4161/chan.4.1.10227

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  28 in total

1.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

Review 2.  Genotype-specific risk stratification and management of patients with long QT syndrome.

Authors:  Alon Barsheshet; Olena Dotsenko; Ilan Goldenberg
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-11-08       Impact factor: 1.468

Review 3.  Cardiac Delayed Rectifier Potassium Channels in Health and Disease.

Authors:  Lei Chen; Kevin J Sampson; Robert S Kass
Journal:  Card Electrophysiol Clin       Date:  2016-04-01

4.  Physical and functional interaction sites in cytoplasmic domains of KCNQ1 and KCNE1 channel subunits.

Authors:  Jerri Chen; Zhenning Liu; John Creagh; Renjian Zheng; Thomas V McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-13       Impact factor: 4.733

5.  Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome.

Authors:  Jason Costa; Coeli M Lopes; Alon Barsheshet; Arthur J Moss; Dmitriy Migdalovich; Gregory Ouellet; Scott McNitt; Slava Polonsky; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Pyotr G Platonov; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Ilan Goldenberg
Journal:  Heart Rhythm       Date:  2012-01-28       Impact factor: 6.343

Review 6.  Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids.

Authors:  Keenan C Taylor; Charles R Sanders
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-04       Impact factor: 3.747

7.  Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome.

Authors:  Alon Barsheshet; Ilan Goldenberg; Jin O-Uchi; Arthur J Moss; Christian Jons; Wataru Shimizu; Arthur A Wilde; Scott McNitt; Derick R Peterson; Wojciech Zareba; Jennifer L Robinson; Michael J Ackerman; Michael Cypress; Daniel A Gray; Nynke Hofman; Jorgen K Kanters; Elizabeth S Kaufman; Pyotr G Platonov; Ming Qi; Jeffrey A Towbin; G Michael Vincent; Coeli M Lopes
Journal:  Circulation       Date:  2012-03-28       Impact factor: 29.690

8.  Receptor Species-dependent Desensitization Controls KCNQ1/KCNE1 K+ Channels as Downstream Effectors of Gq Protein-coupled Receptors.

Authors:  Marie-Cécile Kienitz; Dilyana Vladimirova; Christian Müller; Lutz Pott; Andreas Rinne
Journal:  J Biol Chem       Date:  2016-11-10       Impact factor: 5.157

Review 9.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 10.  Congenital long QT syndromes: prevalence, pathophysiology and management.

Authors:  Alon Barsheshet; Olena Dotsenko; Ilan Goldenberg
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.